Top diabetes drugs in the United States based on revenue in 2011-2012 (in million U.S. dollars)

This statistic represents the top diabetes drugs in the United States, based on revenue between July 2011 and June 2012. In this period, diabetes drug Actos generated around 2.7 billion U.S. dollars of revenues.

Download this statistic as XLS, PNG and PDF?
Basic Account
  • Access to basic statistics (approx. 7%)
  • Common download functions
Premium Account
$588per year*
  • All the advantages of the Basic Account
  • Instant access to all statistics
  • Download as XLS, PNG and PDF
 Revenue in million U.S. dollars
Actos 2,736.4
Januvia 2,323.8
Lantus 2,064.7
Lantus Solostar 1,773.3
Novolog 1,073.7
Humalog 1,004.1
Levemir 947.8
Novolog Flexpen 897
Janumet 841.2
Victoza 3-Pak 587.9
Source information for logged in users only.
Show our solutions
You may also be interested in...
Show more
Market Analytics
Recent Statistics
Related market forecasts
Recommended studies and dossiers

Find the proper statistic fast and easy: